These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37994953)

  • 1. Mpox and HIV-Collision of Two Diseases.
    Zucker J; Hazra A; Titanji BK
    Curr HIV/AIDS Rep; 2023 Dec; 20(6):440-450. PubMed ID: 37994953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mpox and HIV: a Narrative Review.
    Saldana CS; Kelley CF; Aldred BM; Cantos VD
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):261-269. PubMed ID: 37178205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mpox in people living with HIV.
    Maan I; Kohli M; Gilson R
    Curr Opin Infect Dis; 2024 Feb; 37(1):1-7. PubMed ID: 38112084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between HIV and Severe Mpox in an Atlanta Cohort.
    Aldred B; Scott JY; Aldredge A; Gromer DJ; Anderson AM; Cartwright EJ; Colasanti JA; Hall B; Jacob JT; Kalapila A; Kandiah S; Kelley CF; Lyles RH; Marconi VC; Nguyen ML; Rebolledo PA; Sheth AN; Szabo B; Titanji BK; Wiley Z; Workowski K; Cantos VD
    J Infect Dis; 2024 Mar; 229(Supplement_2):S234-S242. PubMed ID: 38001044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mpox (Monkeypox) Virus and Its Co-Infection with HIV, Sexually Transmitted Infections, or Bacterial Superinfections: Double Whammy or a New Prime Culprit?
    Liu BM; Rakhmanina NY; Yang Z; Bukrinsky MI
    Viruses; 2024 May; 16(5):. PubMed ID: 38793665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications.
    Pinnetti C; Cimini E; Mazzotta V; Matusali G; Vergori A; Mondi A; Rueca M; Batzella S; Tartaglia E; Bettini A; Notari S; Rubino M; Tempestilli M; Pareo C; Falasca L; Del Nonno F; Scarabello A; Camici M; Gagliardini R; Girardi E; Vaia F; Maggi F; Agrati C; Antinori A
    Lancet Infect Dis; 2024 Feb; 24(2):e127-e135. PubMed ID: 37778364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mpox in people with HIV: A narrative review.
    Nakamura H; Yamamoto K
    HIV Med; 2024 Aug; 25(8):910-918. PubMed ID: 38745559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Tecovirimat Treatment for Mpox Disease Among People With HIV.
    Aldred B; Lyles RH; Scott JY; Gromer DJ; Aldredge A; Workowski KA; Wiley Z; Titanji BK; Szabo B; Sheth AN; Rebolledo PA; Nguyen ML; Marconi VC; Kelley CF; Kandiah S; Kalapila A; Jacob JT; Hall B; Colasanti JA; Cartwright EJ; Cantos VD
    JAMA Intern Med; 2024 Mar; 184(3):275-279. PubMed ID: 38190312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of fatal monkeypox infection: necropsy and molecular findings, with some considerations related to clinical management.
    Paniagua-García M; Casimiro-Soriguer CS; Chinchón D; Navarro-Amuedo MD; Luque-Márquez R; de Álava E; Lepe JA; Cisneros JM
    Clin Microbiol Infect; 2024 Mar; 30(3):395.e1-395.e4. PubMed ID: 38042367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
    Aden D; Zaheer S; Kumar R; Ranga S
    J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Mpox Infections in People With Uncontrolled Human Immunodeficiency Virus.
    Govind A; Lazarte SM; Kitchell E; Chow JY; Estelle CD; Fixsen E; Helm C; Jain MK; Mehta R; Perl TM; Sutaria JM; Thomas C; Dominguez AR; Utay NS
    Clin Infect Dis; 2023 May; 76(10):1843-1846. PubMed ID: 36718662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Presentation of Mpox in People With and Without HIV in the United Kingdom During the 2022 Global Outbreak.
    Pilkington V; Quinn K; Campbell L; Payne L; Brady M; Post FA
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):581-586. PubMed ID: 37071153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mpox (monkeypox) risk and mortality associated with HIV infection: a national case-control study in Nigeria.
    Yinka-Ogunleye A; Dalhat M; Akinpelu A; Aruna O; Garba F; Ahmad A; Adeleye A; Botson I; Oluwafemi B; Ogunbode O; Amao L; Ekripo U; Aliyu GG; Adetifa I; Ihekweazu C; Abubakar I
    BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 38035733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study.
    Ogoina D; Dalhat MM; Denue BA; Okowa M; Chika-Igwenyi NM; Yusuff HA; Christian UC; Adekanmbi O; Ojimba AO; Aremu JT; Habila KL; Oiwoh SO; Tobin EA; Johnson SM; Olaitan A; Onyeaghala C; Gomerep SS; Alasia D; Onukak AE; Mmerem J; Unigwe U; Falodun O; Kwaghe V; Awang SK; Sunday M; Maduka CJ; Na'uzo AM; Owhin SO; Mohammed AA; Adeiza MA;
    Lancet Infect Dis; 2023 Dec; 23(12):1418-1428. PubMed ID: 37625431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak.
    Essajee NM; Oddo-Moise H; Hagensee ME; Lillis RA; Maffei J; Butler I; Lovett A; Sokol T; Clement ME
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):587-592. PubMed ID: 37424520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of immunosuppression on the mortality and hospitalization of Monkeypox: a systematic review and meta-analysis of the 2022 outbreak.
    Azzam A; Khaled H; Salem H; Ahmed A; Heniedy AM; Hassan HS; Hassan A; El-Mahdy TS
    Virol J; 2024 Jun; 21(1):130. PubMed ID: 38840177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
    McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
    Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology and Monkeypox virus Localization in Tissues From Immunocompromised Patients With Severe or Fatal Mpox.
    Ritter JM; Martines RB; Bhatnagar J; Rao AK; Villalba JA; Silva-Flannery L; Lee E; Bullock HA; Hutson CL; Cederroth T; Harris CK; Hord K; Xu Y; Brown CA; Guccione JP; Miller M; Paddock CD; Reagan-Steiner S;
    J Infect Dis; 2024 Mar; 229(Supplement_2):S219-S228. PubMed ID: 38243606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mpox severity and associated hospitalizations among people with HIV and related immunosuppression in Brazil.
    Silva MST; Coutinho C; Torres TS; Peixoto EM; Bastos MO; Mesquita MB; Tavares ICF; Andrade HB; Reges PPS; Martins PS; Echeverría-Guevara A; Moreira RI; Lessa FCS; Hoagland B; Nunes EP; Cardoso SW; Veloso VG; Grinsztejn B;
    AIDS; 2024 Jan; 38(1):105-113. PubMed ID: 37812389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
    Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.